Coronavirus. https://www.who.int/health-topics/coronavirus#tab=tab_1. Accessed 30 Jan 2023.

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020;36. https://doi.org/10.1002/dmrr.3319.

Chen M, Zhu B, Chen D, Hu X, Xu X, Shen WJ, et al. COVID-19 may increase the risk of insulin resistance in adult patients without diabetes: a 6-month prospective study. Endocr Pract. 2021;27:834–41.

Article  PubMed  PubMed Central  Google Scholar 

Khunti K, Prato S del, Mathieu C, Kahn SE, Gabbay RA, Buse JB. Covid-19, hyperglycemia, and new-onset diabetes. Diabetes Care. 2021;44:2645–55.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rubino F, Amiel SA, Zimmet P, Alberti G, Bornstein S, Eckel RH, et al. New-onset diabetes in Covid-19. N. Engl J Med. 2020;383:789–90.

Article  PubMed  Google Scholar 

Schlesinger S, Neuenschwander M, Lang A, Pafili K, Kuss O, Herder C, et al. Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis. Diabetologia 2021;64:1480–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Langouche L, van den Berghe G, Gunst J. Hyperglycemia and insulin resistance in COVID-19 versus non-COVID critical illness: Are they really different? Crit Care. 2021;25:437.

Article  PubMed  PubMed Central  Google Scholar 

Montefusco L, ben Nasr M, D’Addio F, Loretelli C, Rossi A, Pastore I, et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021;3:774–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Reiterer M, Rajan M, Gómez-Banoy N, Lau JD, Gomez-Escobar LG, Ma L, et al. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metab. 2021;33:2174–88.e5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wan L, Gao Q, Deng Y, Ke Y, Ma E, Yang H, et al. GP73 is a glucogenic hormone contributing to SARS-CoV-2-induced hyperglycemia. Nat Metab. 2022;4:29–43.

Article  CAS  PubMed  Google Scholar 

Cartin-Ceba R, Khatua B, El-Kurdi B, Trivedi S, Kostenko S, Imam Z, et al. Evidence showing lipotoxicity worsens outcomes in covid-19 patients and insights about the underlying mechanisms. iScience. 2022;25:104322.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Soto ME, Guarner-Lans V, Díaz-Díaz E, Manzano-Pech L, Palacios-Chavarría A, Valdez-Vázquez RR, et al. Hyperglycemia and loss of redox homeostasis in COVID-19 patients. Cells 2022;11. https://doi.org/10.3390/cells11060932.

Hayden MR. An immediate and long-term complication of COVID-19 may be Type 2 diabetes mellitus: the central role of β-cell dysfunction, apoptosis and exploration of possible mechanisms. Cells. 2020;9. https://doi.org/10.3390/cells9112475.

Müller JA, Groß R, Conzelmann C, Krüger J, Merle U, Steinhart J, et al. SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas. Nat Metab. 2021;3:149–65.

Article  PubMed  Google Scholar 

Kazakou P, Lambadiari V, Ikonomidis I, Kountouri A, Panagopoulos G, Athanasopoulos S, et al. Diabetes and COVID-19; a bidirectional interplay. Front Endocrinol. 2022;13. https://doi.org/10.3389/fendo.2022.780663.

Laurenzi A, Caretto A, Molinari C, Mercalli A, Melzi R, Nano R, et al. No evidence of long-term disruption of glycometabolic control after SARS-CoV-2 infection. J Clin Endocrinol Metab. 2022;107:e1009–e1019.

Article  PubMed  Google Scholar 

Liu Y, Lu R, Wang J, Cheng Q, Zhang R, Zhang S, et al. Diabetes, even newly defined by HbA1c testing, is associated with an increased risk of in-hospital death in adults with COVID-19. BMC Endocr Disord. 2021;21. https://doi.org/10.1186/S12902-021-00717-6.

Lampasona V, Secchi M, Scavini M, Bazzigaluppi E, Brigatti C, Marzinotto I, et al. Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study. Diabetologia. 2020;63:2548–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cariou B, Pichelin M, Goronflot T, Gonfroy C, Marre M, Raffaitin-Cardin C, et al. Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO study. Diabetes Res Clin Pract. 2021;175. https://doi.org/10.1016/J.DIABRES.2021.108695.

Ryrsø CK, Dungu AM, Hegelund MH, Jensen AV, Sejdic A, Faurholt-Jepsen D, et al. Comparison of body composition, physical capacity, and immuno-metabolic profile of hospitalized patients with community-acquired pneumonia caused COVID-19, influenza, and bacteria. In: European Respiratory Journal. European Respiratory Society (ERS), 2021, p. PA3266.

Plummer MP, Rait L, Finnis ME, French CJ, Bates CCRN S, Douglas J. et al. Diabetes mellitus, glycaemic control and severe COVID-19 in the Australian Critical Care Setting—a nested cohort study. Australian Critical Care. 2022. https://doi.org/10.1016/j.aucc.2022.05.002.

Clinical Spectrum | COVID-19 Treatment Guidelines. https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/. Accessed 30 Jan 2023.

Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr. 1982;36:936–42.

Article  CAS  PubMed  Google Scholar 

Tůma P, Gojda J. Rapid determination of branched chain amino acids in human blood plasma by pressure-assisted capillary electrophoresis with contactless conductivity detection. Electrophoresis. 2015;36:1969–75.

Article  PubMed  Google Scholar 

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.

Article  CAS  PubMed  Google Scholar 

Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462–70.

Article  CAS  PubMed  Google Scholar 

Kile AJ, Hanna C, Hannon TS, Kirkman MS, Considine RV, Patel Y, et al. The linearized disposition index augments understanding of treatment effects in diabetes. Am J Physiol Endocrinol Metab. 2021;320:E169–E177.

Article  CAS  PubMed  Google Scholar 

Association AD. Classification and diagnosis of diabetes: standards of medical care in diabetes—2020. Diabetes Care. 2020;43:S14–S31.

Article  Google Scholar 

Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol Respir Environ Exerc Physiol. 1983;55:628–34.

CAS  PubMed  Google Scholar 

Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism. 1988;37:287–301.

Article  CAS  PubMed  Google Scholar 

Mifflin MD, St Jeor ST, Hill LA, Scott BJ, Daugherty SA, Koh YO. A new predictive equation for resting energy expenditure in healthy individuals. Am J Clin Nutr. 1990;51:241–7.

Article  CAS  PubMed  Google Scholar 

Niederer LE, Miller H, Haines KL, Molinger J, Whittle J, MacLeod DB, et al. Prolonged progressive hypermetabolism during COVID-19 hospitalization undetected by common predictive energy equations. Clin Nutr ESPEN. 2021;45:341–50.

Article  PubMed  PubMed Central  Google Scholar 

Lakenman PLM, van der Hoven B, Schuijs JM, Eveleens RD, van Bommel J, Olieman JF, et al. Energy expenditure and feeding practices and tolerance during the acute and late phase of critically ill COVID-19 patients. Clin Nutr ESPEN. 2021;43:383–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

von Renesse J, von Bonin S, Held HC, Schneider R, Seifert AM, Seifert L, et al. Energy requirements of long-term ventilated COVID-19 patients with resolved SARS-CoV-2 infection. Clin Nutr ESPEN. 2021;44:211–7.

Article  Google Scholar 

Yu PJ, Cassiere H, DeRosa S, Bocchieri K, Yar S, Hartman A. Hypermetabolism and coronavirus disease 2019. J Parenter Enter Nutr. 2020;44:1234–6.

Article  CAS  Google Scholar 

Martindale R, Patel JJ, Taylor B, Arabi YM, Warren M, McClave SA. Nutrition therapy in critically ill patients with coronavirus disease 2019. JPEN J Parenter Enter Nutr. 2020;44:1174–84.

Article  CAS  Google Scholar 

Whittle J, Molinger J, MacLeod D, Haines K, Wischmeyer PE. Persistent hypermetabolism and longitudinal energy expenditure in critically ill patients with COVID-19. Crit Care. 2020;24:581.

Article  PubMed  PubMed Central  Google Scholar 

McClave SA, Taylor BE, Martindale RG, Warren MM, Johnson DR, Braunschweig C, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient. J Parenter Enter Nutr. 2016;40:159–211.

Article  CAS  Google Scholar 

Brillon DJ, Zheng B, Campbell RG, Matthews DE. Effect of cortisol on energy expenditure and amino acid metabolism in humans. Am J Physiol Endocrinol Metab. 1995;268. https://doi.org/10.1152/ajpendo.1995.268.3.e501.

Sathish T, Kapoor N, Cao Y, Tapp RJ, Zimmet P. Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes Metab. 2021;23:870–4.

Article  CAS  PubMed  Google Scholar 

Makris K, Spanou L. Is there a relationship between mean blood glucose and glycated hemoglobin? J Diabetes Sci Technol. 2011;5:1572.

Article  PubMed  PubMed Central  Google Scholar 

Shestakova M, Kononenko I, Kalmykov Z, Markova T, Kaplun E, Lysenko M, et al. Glycated hemoglobin level dynamics in COVID-19 survivors: 12 months follow-up study after discharge from hospital. PLoS ONE. 2022;17. https://doi.org/10.1371/JOURNAL.PONE.0275381.

Qi D, Rodrigues B. Glucocorticoids produce whole body insulin resistance with changes in cardiac metabolism. Am J Physiol Endocrinol Metab. 2007;292. https://doi.org/10.1152/ajpendo.00453.2006.

Wu J, MacKie SL, Pujades-Rodriguez M. Glucocorticoid dose-dependent risk of type 2 diabetes in six immune-mediated inflammatory diseases: a population-based cohort analysis. BMJ Open Diabetes Res Care. 2020;8. https://doi.org/10.1136/BMJDRC-2020-001220.

Fine NHF, Doig CL, Elhassan YS, Vierra NC, Marchetti P, Bugliani M, et al. Glucocorticoids reprogram b-cell signaling to preserve insulin secretion. In: Diabetes. American Diabetes Association Inc.; 2018. p. 278–90.

Vanweert F, Schrauwen P, Phielix E. Role of branched-chain amino acid metabolism in the pathogenesis of obesity and type 2 diabetes-related metabolic disturbances BCAA metabolism in type 2 diabetes. Nutr Diabetes. 2022;12:35.

Article  CAS  PubMed  PubMed Central  Google Scholar